Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 9.11% is 83% above its 5-year average of 4.99%, near the high end of its 5-year range (0.11%–9.11%).
As of the fiscal period ended Wednesday, December 31, 2025. 15.68% above its 12-month average of 7.88%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
9.11%
RETURN ON ASSETS (ROA) AVG TTM
7.88%
RETURN ON ASSETS (ROA) AVG 3Y
6.26%
RETURN ON ASSETS (ROA) AVG 5Y
4.99%
RETURN ON ASSETS (ROA) AVG 10Y
4.61%
RETURN ON ASSETS (ROA) AVG 15Y
4.93%
RETURN ON ASSETS (ROA) AVG 20Y
8.56%
CURRENT VS TTM AVG
+15.68%
CURRENT VS 3Y AVG
+45.47%
CURRENT VS 5Y AVG
+82.50%
CURRENT VS 10Y AVG
+97.57%
CURRENT VS 15Y AVG
+84.71%
CURRENT VS 20Y AVG
+6.48%
SECTOR MEDIAN · HEALTHCARE
4.93%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+84.79%
vs the sector median at left
AstraZeneca PLC
Market Cap
$131.97B
Return on Assets (ROA)
9.11%
TTM Avg
7.88%
3Y Avg
6.26%
5Y Avg
4.99%
Market Cap
$129.13B
Return on Assets (ROA)
7.21%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$127.69B
Return on Assets (ROA)
8.41%
TTM Avg
-0.92%
3Y Avg
3.28%
5Y Avg
1.99%
Market Cap
$137.03B
Return on Assets (ROA)
4.33%
TTM Avg
4.68%
3Y Avg
5.89%
5Y Avg
6.01%
Market Cap
$137.35B
Return on Assets (ROA)
1.16%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$125.58B
Return on Assets (ROA)
15.04%
TTM Avg
13.09%
3Y Avg
12.00%
5Y Avg
11.68%
Market Cap
$121.59B
Return on Assets (ROA)
16.38%
TTM Avg
6.37%
3Y Avg
11.74%
5Y Avg
14.58%
Market Cap
$107.93B
Return on Assets (ROA)
5.16%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $131.97B | 9.11% | 7.88% | 6.26% | 4.99% |
| Stryker Corporation (SYK)vs › | $129.13B | 7.21% | 6.88% | 7.02% | 6.41% |
| Bristol-Myers Squibb Company (BMY)vs › | $127.69B | 8.41% | -0.92% | 3.28% | 1.99% |
| Danaher Corporation (DHR)vs › | $137.03B | 4.33% | 4.68% | 5.89% | 6.01% |
| CVS Health Corp. (CVS)vs › | $137.35B | 1.16% | 1.25% | 1.93% | 2.38% |
| Intuitive Surgical, Inc. (ISRG)vs › | $125.58B | 15.04% | 13.09% | 12.00% | 11.68% |
| Pfizer Inc. (PFE)vs › | $140.86B | 3.61% | 3.75% | 6.08% | 7.08% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.59B | 16.38% | 6.37% | 11.74% | 14.58% |
| Medtronic plc (MDT)vs › | $107.93B | 5.16% | 5.13% | 4.62% | 4.65% |
| GSK plc (GSK)vs › | $105.01B | 7.15% | 6.85% | 11.28% | 9.07% |
ROA
9.1%
ROE
21.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 8.99% |
| 2024-12-31 | 6.76% |
| 2023-12-31 | 5.89% |
| 2022-12-31 | 3.41% |
| 2021-12-31 | 0.11% |
| 2020-12-31 | 4.79% |
| 2019-12-31 | 2.18% |
| 2018-12-31 | 3.55% |
| 2017-12-31 | 4.74% |
| 2016-12-31 | 5.60% |
| 2015-12-31 | 4.70% |
| 2014-12-31 | 2.10% |
| 2013-12-31 | 4.57% |
| 2012-12-31 | 11.66% |
| 2011-12-31 | 18.77% |
| 2010-12-31 | 14.35% |
| 2009-12-31 | 13.69% |
| 2008-12-31 | 12.99% |
| 2007-12-31 | 11.67% |
| 2006-12-31 | 20.19% |
| 2005-12-31 | 18.95% |
| 2004-12-31 | 14.28% |
| 2003-12-31 | 12.88% |
| 2002-12-31 | 13.15% |
| 2001-12-31 | 15.72% |
| 2000-12-31 | 13.77% |
| 1999-12-31 | 5.77% |
| 1998-12-31 | 13.20% |
| 1997-12-31 | 14.57% |
| 1996-12-31 | 12.86% |
